$19.75
0.381.96%
Pre-Market: Jul 19, 4:23 PM EDT
15 minutes delayed
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
05/07/2024 | PCRX | Pacira BioSciences | FY | 2024 | — | — | — | $680.00M | $705.00M | $691.61M | Get Alert |
02/29/2024 | PCRX | Pacira BioSciences | FY | 2024 | — | — | — | $680.00M | $705.00M | $722.45M | Get Alert |
01/04/2024 | PCRX | Pacira BioSciences | Q4 | 2023 | — | — | — | $181.20M | $181.20M | $179.91M | Get Alert |
01/04/2024 | PCRX | Pacira BioSciences | FY | 2023 | — | — | — | $675.00M | $675.00M | $677.30M | Get Alert |
01/05/2023 | PCRX | Pacira BioSciences | FY | 2022 | $2.50 | — | $2.77 | $666.80M | $666.80M | $671.30M | Get Alert |
10/13/2022 | PCRX | Pacira BioSciences | Q3 | 2022 | — | — | — | $167.50M | $167.50M | $172.72M | Get Alert |
07/14/2022 | PCRX | Pacira BioSciences | Q2 | 2022 | — | — | — | $169.40M | $169.40M | $174.91M | Get Alert |
04/12/2022 | PCRX | Pacira BioSciences | Q1 | 2022 | — | — | — | $157.40M | $158.40M | $162.85M | Get Alert |
01/06/2022 | PCRX | Pacira BioSciences | FY | 2021 | — | — | — | $540.70M | $541.70M | $534.70M | Get Alert |
07/13/2021 | PCRX | Pacira BioSciences | Q2 | 2021 | — | — | — | $135.60M | $135.60M | $128.01M | Get Alert |
01/07/2021 | PCRX | Pacira BioSciences | FY | 2020 | — | — | — | $429.60M | $429.60M | $427.70M | Get Alert |
07/06/2020 | PCRX | Pacira BioSciences | Q2 | 2020 | — | — | — | $75.50M | $75.50M | $57.81M | Get Alert |
02/20/2020 | PCRX | Pacira BioSciences | FY | 2020 | — | — | — | $485.00M | $500.00M | $495.91M | Get Alert |
01/09/2020 | PCRX | Pacira BioSciences | FY | 2019 | — | — | — | $421.00M | $421.00M | $418.06M | Get Alert |
01/09/2020 | PCRX | Pacira BioSciences | Q4 | 2019 | — | — | — | $122.40M | $122.40M | $119.70M | Get Alert |
11/07/2019 | PCRX | Pacira BioSciences | FY | 2019 | — | — | — | $408.00M | $420.00M | $418.43M | Get Alert |
There have been no specific sales or earnings guidance reported for Pacira BioSciences in recent months.
Browse guidance and forecast on all stocks.